The stock of Palisade Bio Inc. (PALI) has seen a -9.94% decrease in the past week, with a -5.84% drop in the past month, and a -35.27% decrease in the past quarter. The volatility ratio for the week is 12.37%, and the volatility levels for the past 30 days are at 9.01% for PALI. The simple moving average for the past 20 days is -9.52% for PALI’s stock, with a -63.73% simple moving average for the past 200 days.
Is It Worth Investing in Palisade Bio Inc. (NASDAQ: PALI) Right Now?
and a 36-month beta value of 1.52. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
The average price predicted for Palisade Bio Inc. (PALI) by analysts is $10.50, which is $9.05 above the current market price. The public float for PALI is 1.36M, and at present, short sellers hold a 23.98% of that float. On May 25, 2023, the average trading volume of PALI was 1.52M shares.
PALI) stock’s latest price update
The stock of Palisade Bio Inc. (NASDAQ: PALI) has decreased by -7.64 when compared to last closing price of 1.57. Despite this, the company has experienced a -9.94% fall in its stock price over the last five trading sessions.
PALI Trading at -19.77% from the 50-Day Moving Average
After a stumble in the market that brought PALI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.47% of loss for the given period.
Volatility was left at 9.01%, however, over the last 30 days, the volatility rate increased by 12.37%, as shares sank -9.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.60% lower at present.
During the last 5 trading sessions, PALI fell by -9.94%, which changed the moving average for the period of 200-days by -94.42% in comparison to the 20-day moving average, which settled at $1.5945. In addition, Palisade Bio Inc. saw -72.12% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PALI starting from Finley John David, who purchase 19,481 shares at the price of $0.14 back on Sep 01. After this action, Finley John David now owns 148,727 shares of Palisade Bio Inc., valued at $2,799 using the latest closing price.
Finley John David, the Chief Financial Officer of Palisade Bio Inc., purchase 7,350 shares at $0.16 during a trade that took place back on Aug 23, which means that Finley John David is holding 129,246 shares at $1,176 based on the most recent closing price.
Stock Fundamentals for PALI
Equity return is now at value -115.70, with -90.00 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 4.85.
Conclusion
To sum up, Palisade Bio Inc. (PALI) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
